7Baggers
 Telomir Pharmaceuticals Unveils Promising Preclinical Data  TipRanks Wed, 12 Nov 2025 12:42:48 GMT
 Thyroid Hormone Receptor TRβ Identified as New Target for Prostate Cancer Treatment  Inside Precision Medicine Mon, 10 Nov 2025 21:31:37 GMT
 published on: 2025-10-28 02:03:32  fcp.pa.gov.br Tue, 28 Oct 2025 05:03:32 GMT

Telomir Pharmaceuticals
(NASDAQ:TELO) 


Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company is headquartered in Baltimore, Maryland.

Founded: 2021
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends